The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...

Investigators compared the outcomes of patients with type 2 diabetes who continued versus stopped metformin after progressing to stage 4 chronic kidney disease.

The future of healthcare is defined by this blend of technology and human expertise, offering new hope for a more efficient ...

Diabetes India has announced a nationwide campaign for early detection of Chronic Kidney Disease (CKD) in diabetes patients.

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

Body weight cycling in type 1 diabetes is associated with increased risk of chronic kidney disease. Maintaining stable weight ...

Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

An unusual swelling in the legs and feet could indicate the onset of kidney damage. When the kidneys struggle to eliminate ...

Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

Denmark: A recent study published in the Journal of Diabetes and its Complications has explored the role of kidney fat ...